| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |